<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="case-report" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">OURD</journal-id>
<journal-title>Our Dermatol Online</journal-title>
<issn pub-type="epub">2081-9390</issn>
<publisher>
<publisher-name>Our Dermatology Online</publisher-name>
<publisher-loc>Poland</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">OURD-6-304</article-id>
<article-id pub-id-type="doi">10.7241/ourd.20153.81</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Case Report</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Embolis cutis medicamentosa, a rare preventable iatrogenic complication</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Deepadarshan</surname>
<given-names>Kalegowda</given-names>
</name>
<xref ref-type="aff" rid="aff1"/>
<xref ref-type="corresp" rid="cor1"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kavya</surname>
<given-names>Manjunath</given-names>
</name>
<xref ref-type="aff" rid="aff1"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Harish</surname>
<given-names>Muddanahalli Rajegowda</given-names>
</name>
<xref ref-type="aff" rid="aff1"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shashikumar</surname>
<given-names>Basavapura Madegowda</given-names>
</name>
<xref ref-type="aff" rid="aff1"/>
</contrib>
</contrib-group>
<aff id="aff1"><italic>Department of Dermatology, Mandya Institute of Medical Sciences, Mandya-571401, Karnataka, India</italic></aff>
<author-notes>
<corresp id="cor1">
<bold>Corresponding author:</bold> Dr. Kalegowda Deepadarshan, E-mail: <email xlink:href="deepadarshan.rani@gmail.com">deepadarshan.rani@gmail.com</email>
</corresp>
</author-notes>
<pub-date pub-type="ppub">
<year>2015</year>
</pub-date>
<volume>6</volume>
<issue>3</issue>
<fpage>304</fpage>
<lpage>306</lpage>
<history>
<date date-type="received"><day>06</day><month>01</month><year>2015</year></date>
<date date-type="accepted"><day>04</day><month>04</month><year>2015</year></date>
</history>
<permissions>
<copyright-statement>Copyright: &#x000a9; Our Dermatol Online 3</copyright-statement>
<copyright-year>2015</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p>
</license>
</permissions>
<abstract>
<p>Embolis cutis medicamentosa is an uncommon iatrogenic complication characterised by variable degree of skin and tissue necrosis, likely to follow intramuscular injection. Intense pain and purplish discoloration of overlying skin, with or without reticulate pattern subsequently followed by tissue necrosis and scarring is highly specific for this syndrome. It has also been reported following intravenous, intra-articular and subcutaneous injections. Herein we are reporting two cases of this rare preventable entity.</p>
</abstract>
<kwd-group>
<kwd>Embolia cutis medicamentosa</kwd>
<kwd>tissue necrosis</kwd>
<kwd>intramuscular</kwd>
<kwd>diclofenac</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="sec1-1" sec-type="intro">
<title>INTRODUCTION</title>
<p>Embolia cutis medicamentosa also known as Nicolau syndrome, livedoid dermatitis characterised by severe painful local necrosis at the site of injected medicament [<xref ref-type="bibr" rid="ref1">1</xref>,<xref ref-type="bibr" rid="ref2">2</xref>]. Intense pain and purplish discoloration of overlying skin, with or without reticulate pattern subsequently followed by tissue necrosis and scarring is highly specific for this syndrome. Initially described by Nicolau and Frudenthal as an adverse effect with use of bismuth salts intramuscularly in syphilis patients [<xref ref-type="bibr" rid="ref3">3</xref>]. Clinically, patient manifests with intense pain at the injection site, followed by bluish discoloration of overlying skin assuming reticulate pattern, referred as non-inflammatory retiform purpura, livedo-like dermatitis.<sup>2</sup> In later stages, discoloured area undergoes necrosis and ulceration may involve sub-cutis and underlying muscles.</p>
</sec>
<sec id="sec1-2" sec-type="cases">
<title>CASE REPORTS</title>
<sec id="sec2-1">
<title>Case 1</title>
<p>A 50 year old male presented with non healing ulcer over the left buttock of one month duration. Patient had fever and generalized body ache one month back, for which he was administered intramuscular injection of diclofenac in outer aspect of left buttock. Immediately after the injection, patient experienced intense pain along with redness followed by bluish discoloration of the overlying skin after two days. Later the entire skin became black with necrosis which eroded over a week. On examination, a solitary well defined ulcer measuring 10&#x00D7;5 cm in size, covered with necrotic tissue (<xref ref-type="fig" rid="F1">Fig. 1</xref>) was noted over the outer aspect of left buttock. Patient was treated with oral and topical antibiotics, without much improvement. Patient was admitted, wound was debrided, and was started on systemic antibiotics. Routine investigations including bleeding time, clotting time were normal. Following daily dressings and systemic antibiotics, wound was covered with healthy granulation tissue in about 2 weeks. Split skin grafting was done to hasten the healing.</p>
<fig id="F1">
<label>Figure 1</label>
<caption>
<p>Case 1 showing well defined ulcer measuring 10&#x00D7;5 cm in size, covered with necrotic tissue.</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="OURD-6-304-g001.tif"/>
</fig>
</sec>
<sec id="sec2-2">
<title>Case 2</title>
<p>A 45 year old female presented with chronic non-healing ulcer of one month duration over the outer aspect of right buttock. Patient had received intramuscular injection of diclofenac for joint pain 3weeks back. Immediately following injection she developed intense pain and blanching of skin. Later over a period of 2 weeks entire blanched area becomes ulcerated and necrotic. On examination, a solitary well defined ulcer measuring 4&#x00D7;6 cm in size, localized to outer aspect of right buttock covered with necrotic tissue was noted (<xref ref-type="fig" rid="F2">Fig. 2</xref>). Patient was admitted and wound debridement was done. After daily dressings and antibiotics, ulcer showed signs of healing. Finally after 2 weeks it healed with scar formation.</p>
<fig id="F2">
<label>Figure 2</label>
<caption>
<p>Case 2 showing well defined ulcer localized to outer aspect of right buttock covered with necrotic tissue.</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="OURD-6-304-g002.tif"/>
</fig>
</sec>
</sec>
<sec id="sec1-3" sec-type="discussion">
<title>DISCUSSION</title>
<p>Embolia cutis medicamentosa or Livedoid-like dermatitis (Nicolau syndrome) is an uncommon iatrogenic complication characterised by variable degree of skin and tissue necrosis, likely to follow intramuscular injection [<xref ref-type="bibr" rid="ref2">2</xref>]. Cases have been reported following intramuscular injection of vitamin-K [<xref ref-type="bibr" rid="ref4">4</xref>], diclofenac [<xref ref-type="bibr" rid="ref5">5</xref>], bismuth [<xref ref-type="bibr" rid="ref6">6</xref>], benzathine penicillin [<xref ref-type="bibr" rid="ref7">7</xref>], gentamycin [<xref ref-type="bibr" rid="ref8">8</xref>] and vaccination [<xref ref-type="bibr" rid="ref9">9</xref>]. It has also been reported following intravenous polidocanol 1&#x0025; [<xref ref-type="bibr" rid="ref10">10</xref>], intra-articular corticosteroids [<xref ref-type="bibr" rid="ref11">11</xref>], subcutaneous injections of pegylated interferon-&#x03B1; [<xref ref-type="bibr" rid="ref12">12</xref>] and sclerotherapy for pyogenic granuloma [<xref ref-type="bibr" rid="ref13">13</xref>].</p>
<p>The exact etio-pathogenesis of this syndrome is not known. Probable explanations for the ischemic necrosis of the skin and deep tissues seen in this syndrome includes, vasospasm secondary to needle prick, pressure of material placed around vessel and embolization of the injected material [<xref ref-type="bibr" rid="ref7">7</xref>]. Cutaneous necrosis seen following bismuth salt injections in syphilis patients were thought to be due to high viscosity of salts causing blockage arterioles. Application of cold compresses can aggravate necrosis [<xref ref-type="bibr" rid="ref14">14</xref>].</p>
<p>Complications like paralysis of limb has been reported which is attributed to embolization of medication into the internal iliac vessels [<xref ref-type="bibr" rid="ref15">15</xref>]. Late complications such as contractures and deformities can occur due to scarring process that needs surgical correction [<xref ref-type="bibr" rid="ref6">6</xref>]. Soft tissue sarcoma can occur as a rare complication at the site of tissue necrosis [<xref ref-type="bibr" rid="ref16">16</xref>].</p>
<p>Diagnosis is mainly clinical. Nicolau syndrome has to be differentiated from necrotising fasciitis. In the latter, there is rapidly spreading infection of the sub-cutis and fascia due to haemolytic streptococci and other anaerobes. Necrotising fasciitis usually occurs following surgery or after a deep penetrating injury and manifests with intense pain with erythema of the skin later becomes purplish and ulcerates. On X-ray there is often presence of air in the tissues. Ultrasound and magnetic resonance imaging often helpful to delineate the extent of damage in the tissues [<xref ref-type="bibr" rid="ref2">2</xref>].</p>
<p>Early institution of treatment has been reported to avert the extent of necrosis. Measures to improve the vascularity such as pentoxyphylline, hyperbaric oxygen, intravenous alprostadil and thrombolysis with heparin has been tried in the immediate post-event period [<xref ref-type="bibr" rid="ref2">2</xref>]. Surgical debridement and systemic antibiotics play pivotal role in controlling infection. Since it can occur to common drugs it is very important for the Dermatologists to be aware of this rare iatrogenic disfiguring condition.</p>
</sec>
<sec id="sec1-4">
<title>CONSENT</title>
<p>The examination of the patient was conducted according to the Declaration of Helsinki principles.</p>
</sec>
</body>
<back>
<ref-list>
<title>REFERENCES</title>
<ref id="ref1">
<label>1</label>
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Breathnach</surname>
<given-names>SM</given-names>
</name>
</person-group>
<person-group person-group-type="editor">
<name>
<surname>Burns</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Breathnach</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Cox</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Griffiths</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Drug reactions</article-title>
<source>Rooks Textbook of Dermatology</source>
<year>2010</year>
<edition>8th ed</edition>
<publisher-loc>Oxford</publisher-loc>
<publisher-name>Blackwell Publishing</publisher-name>
<fpage>75.1</fpage>
<lpage>160</lpage>
</nlm-citation>
</ref>
<ref id="ref2">
<label>2</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nischal</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Basavaraj</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Swaroop</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Agrawal</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Sathyanarayana</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Umashankar</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Nicolau Syndrome: An Iatrogenic Cutaneous Necrosis</article-title>
<source>J Cutan Aesthet Surg</source>
<year>2009</year>
<volume>2</volume>
<fpage>92</fpage>
<lpage>5</lpage>
</nlm-citation>
</ref>
<ref id="ref3">
<label>3</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kohler</surname>
<given-names>LD</given-names>
</name>
<name>
<surname>Schwedler</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Worret</surname>
<given-names>WI</given-names>
</name>
</person-group>
<article-title>Embolia cutis medicamentosa</article-title>
<source>Int J Dermatol</source>
<year>1997</year>
<volume>36</volume>
<fpage>197</fpage>
</nlm-citation>
</ref>
<ref id="ref4">
<label>4</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koklu</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Sarici</surname>
<given-names>SU</given-names>
</name>
<name>
<surname>Altun</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Erdeve</surname>
<given-names>O</given-names>
</name>
</person-group>
<article-title>Nicolau syndrome induced by intramuscular vitamin K in a premature newborn</article-title>
<source>Eur J Pediatr</source>
<year>2009</year>
<volume>168</volume>
<fpage>1541</fpage>
<lpage>2</lpage>
</nlm-citation>
</ref>
<ref id="ref5">
<label>5</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Murthy</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Siddalingappa</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Suresh</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Nicolau&#x2019;s syndrome following diclofenac administration: A report of two cases</article-title>
<source>Indian J Dermatol Venereol Leprol</source>
<year>2007</year>
<volume>73</volume>
<fpage>429</fpage>
<lpage>31</lpage>
</nlm-citation>
</ref>
<ref id="ref6">
<label>6</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Corazza</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Capozzi</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Virgilit</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Five cases of livedo-like dermatitis (Nicolau&#x2019;s syndrome) due to bismuth salts and various other non-steroidal anti-inflammatory drugs</article-title>
<source>J Eur Acad Dermatol Venereol</source>
<year>2001</year>
<volume>15</volume>
<fpage>585</fpage>
<lpage>8</lpage>
</nlm-citation>
</ref>
<ref id="ref7">
<label>7</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Sousa</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Dang</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rataboli</surname>
<given-names>PV</given-names>
</name>
</person-group>
<article-title>Nicolau syndrome following intramuscular benzathine penicillin</article-title>
<source>J Postgrad Med</source>
<year>2008</year>
<volume>54</volume>
<fpage>332</fpage>
<lpage>4</lpage>
</nlm-citation>
</ref>
<ref id="ref8">
<label>8</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>DH</given-names>
</name>
<name>
<surname>Ahn</surname>
<given-names>HH</given-names>
</name>
<name>
<surname>Kye</surname>
<given-names>YC</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>JE</given-names>
</name>
</person-group>
<article-title>Nicolau syndrome involving whole ipsilateral limb induced by intramuscular administration of gentamycin</article-title>
<source>Indian J Dermatol Venereol Leprol</source>
<year>2014</year>
<volume>80</volume>
<fpage>96</fpage>
</nlm-citation>
</ref>
<ref id="ref9">
<label>9</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kienast</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Mentze</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Hoeger</surname>
<given-names>PH</given-names>
</name>
</person-group>
<article-title>Nicolau&#x2019;s syndrome induced by intramuscular vaccinations in children: Report of seven patients and review of the literature</article-title>
<source>Clin Exp Dermatol</source>
<year>2008</year>
<volume>33</volume>
<fpage>555</fpage>
<lpage>8</lpage>
</nlm-citation>
</ref>
<ref id="ref10">
<label>10</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Geukens</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Rabe</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Bieber</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Embolia cutis medicamentosa of the foot after sclerotherapy</article-title>
<source>Eur J Dermatol</source>
<year>1999</year>
<volume>9</volume>
<fpage>132</fpage>
<lpage>3</lpage>
</nlm-citation>
</ref>
<ref id="ref11">
<label>11</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cherasse</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kahn</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Mistrih</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Maillard</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Strauss</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Tavernier</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Nicolau&#x2019;s syndrome after local glucocorticoid injection</article-title>
<source>Joint Bone Spine</source>
<year>2003</year>
<volume>70</volume>
<fpage>390</fpage>
<lpage>2</lpage>
</nlm-citation>
</ref>
<ref id="ref12">
<label>12</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sonntag</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hodzic-Avdagic</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Bruch-Gerharz</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Neumann</surname>
<given-names>NJ</given-names>
</name>
</person-group>
<article-title>Embolia cutis medicamentosa after subcutaneous injection of pegylated interferon-&#945;</article-title>
<source>Hautarzt</source>
<year>2005</year>
<volume>56</volume>
<fpage>968</fpage>
<lpage>9</lpage>
</nlm-citation>
</ref>
<ref id="ref13">
<label>13</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nirmal</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Segu</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Sacchidanand</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Deshpande</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Nicolau syndrome following sclerotherapy for pyogenic granuloma</article-title>
<source>Indian J Dermatol Venereol Leprol</source>
<year>2014</year>
<volume>80</volume>
<fpage>484</fpage>
</nlm-citation>
</ref>
<ref id="ref14">
<label>14</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Senel</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Ada</surname>
<given-names>S</given-names>
</name>
<name>
<surname>G&#252;le&#231;</surname>
<given-names>AT</given-names>
</name>
<name>
<surname>Ca&#287;lar</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Nicolau syndrome aggravated by cold application after i.m. diclofenac</article-title>
<source>J Dermatol</source>
<year>2008</year>
<volume>35</volume>
<fpage>18</fpage>
<lpage>20</lpage>
</nlm-citation>
</ref>
<ref id="ref15">
<label>15</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miranda</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Rozenfeld</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Olivera</surname>
<given-names>SP</given-names>
</name>
</person-group>
<article-title>A systematic review of the nonallergic adverse reactions following benzathine penicilline injections</article-title>
<source>J Vasc Br</source>
<year>2004</year>
<volume>3</volume>
<fpage>253</fpage>
<lpage>60</lpage>
</nlm-citation>
</ref>
<ref id="ref16">
<label>16</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mayrink</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mendon&#231;a</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>da Costa</surname>
<given-names>PR</given-names>
</name>
</person-group>
<article-title>Soft-tissue sarcoma arising from a tissue necrosis caused by an intramuscular injection of diclofenac</article-title>
<source>Plast Reconstr Surg</source>
<year>2003</year>
<volume>112</volume>
<fpage>1970</fpage>
<lpage>1</lpage>
</nlm-citation>
</ref>
</ref-list>
<fn-group>
<fn fn-type="supported-by">
<p><bold>Source of Support:</bold> Nil,</p>
</fn>
<fn fn-type="conflict">
<p><bold>Conflict of Interest:</bold> None declared.</p>
</fn>
</fn-group>
</back>
</article>
